Shattuck Labs (STTK) Cash from Investing Activities (2019 - 2026)
Shattuck Labs' (STTK) quarterly Cash from Investing Activities came in at $23.8 million in Q1 2026, up 52.87% year-on-year from $15.6 million in Q1 2025, and up 19.24% on a QoQ basis from $20.0 million in Q4 2025.
Shattuck Labs (STTK) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Cash from Investing Activities data on file, last reported at $23.8 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 52.87% year-over-year to $23.8 million in Q1 2026; TTM through Mar 2026 was $361000.0, a 99.11% decrease from a year earlier, with the FY2025 full-year figure at -$7.9 million, up 7.33% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $23.8 million, up from $20.0 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for STTK reached as high as $55.9 million in Q4 2023 and fell as low as -$43.5 million in Q3 2025.
- Historically, Cash from Investing Activities has averaged $10.5 million across 5 years, with a median of $17.8 million in 2025.
- Across the five-year window, Cash from Investing Activities surged 611.71% in 2023 and slumped 5196.83% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at $31.5 million in 2022, then surged by 77.52% to $55.9 million in 2023, then plunged by 44.5% to $31.0 million in 2024, then slumped by 35.48% to $20.0 million in 2025, then climbed by 19.24% to $23.8 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $23.8 million in Q1 2026, $20.0 million in Q4 2025, and -$43.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -45.51 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 178,242.27 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 172.62 Mn |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | 23.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.85 Mn |
| Mar 31, 2026 | 23.85 Mn |
| Dec 31, 2025 | 20.00 Mn |
| Dec 31, 2025 | 20.00 Mn |
| Sep 30, 2025 | -43.49 Mn |
| Sep 30, 2025 | -43.49 Mn |
| Mar 31, 2025 | 15.60 Mn |
| Mar 31, 2025 | 15.60 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Dec 31, 2024 | 31.00 Mn |
| Sep 30, 2024 | -821,000.00 |
| Sep 30, 2024 | -821,000.00 |
| Jun 30, 2024 | -5.41 Mn |
| Jun 30, 2024 | -5.41 Mn |
| Mar 31, 2024 | -33.28 Mn |
| Mar 31, 2024 | -33.28 Mn |
| Dec 31, 2023 | 55.85 Mn |
| Dec 31, 2023 | 55.85 Mn |
| Sep 30, 2023 | -14.55 Mn |
| Sep 30, 2023 | -14.55 Mn |